---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-227040"
form_type: "8-K"
ticker: "AMGN"
cik: "0000318154"
company_name: "AMGEN INC"
filed_at: "2023-09-01T23:59:59+00:00"
generated_at: "2026-06-11T00:48:14.418772+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Amgen and Horizon resolve FTC lawsuit; consent order clears path to close acquisition in early Q4 2023

## Summary
- Consent order agreement with FTC resolves pending administrative lawsuit related to Amgen's acquisition of Horizon.
- Parties will jointly file to dismiss preliminary injunction motion and dissolve TRO in U.S. District Court for Northern District of Illinois.
- Amgen gave narrow assurance it has no intention or ability to bundle Horizon's TEPEZZA or KRYSTEXXA; no impact on business.
- Acquisition expected to close in early Q4 2023, pending final approvals under Irish law.

## SEC filing metadata
- accession: 0001193125-23-227040
- form_type: 8-K
- ticker: AMGN
- cik: 0000318154
- company_name: AMGEN INC
- filed_at: 2023-09-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318154/000119312523227040/0001193125-23-227040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318154/000119312523227040/d525571d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-227040
- JSON: https://secwatch.observer/filing/0001193125-23-227040.json
- Plain text: https://secwatch.observer/filing/0001193125-23-227040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.